These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 18672309

  • 41. How hypoglycaemia can affect the life of a person with diabetes.
    Frier BM.
    Diabetes Metab Res Rev; 2008 Feb; 24(2):87-92. PubMed ID: 18088077
    [Abstract] [Full Text] [Related]

  • 42. Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing: are there any differences using insulin lispro compared to regular insulin?
    Yuen KC, Amin R, Cook MB, Rhoads SA, Cook DM.
    Horm Res; 2008 Feb; 69(4):233-9. PubMed ID: 18204271
    [Abstract] [Full Text] [Related]

  • 43. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
    Rolla A.
    Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
    [Abstract] [Full Text] [Related]

  • 44. Inhaled insulin.
    Arnolds S, Heise T.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):555-71. PubMed ID: 18054735
    [Abstract] [Full Text] [Related]

  • 45. An effective system of nurse-led diabetes care in rural Africa.
    Gill GV, Price C, Shandu D, Dedicoat M, Wilkinson D.
    Diabet Med; 2008 May; 25(5):606-11. PubMed ID: 18445175
    [Abstract] [Full Text] [Related]

  • 46. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes.
    Geddes J, Schopman JE, Zammitt NN, Frier BM.
    Diabet Med; 2008 Apr; 25(4):501-4. PubMed ID: 18387080
    [Abstract] [Full Text] [Related]

  • 47. Severe hypoglycaemia in insulin-treated Type 2 diabetes.
    Geddes J, Frier BM.
    Diabet Med; 2007 Mar; 24(3):327; author reply 328. PubMed ID: 17305795
    [No Abstract] [Full Text] [Related]

  • 48. Psoriatic exacerbation associated with insulin therapy.
    Moore AF, Soper T, Jones N, Grevelink J, Abourizk N.
    Diabetes Care; 2008 May; 31(5):e31. PubMed ID: 18445711
    [No Abstract] [Full Text] [Related]

  • 49. [Monitoring hypoglycemia in elderly diabetic patients: a prospective study].
    Coutaz M, Nicod M, Chassot M, Morisod J.
    Rev Med Suisse; 2007 Apr 25; 3(108):1071-6. PubMed ID: 17552260
    [Abstract] [Full Text] [Related]

  • 50. Lipoatrophy is a thing of the past, or is it?
    Hussein SF, Siddique H, Coates P, Green J.
    Diabet Med; 2007 Dec 25; 24(12):1470-2. PubMed ID: 17976201
    [Abstract] [Full Text] [Related]

  • 51. [Hypoglycaemia].
    Mokán M.
    Vnitr Lek; 2008 Apr 25; 54(4):387-94. PubMed ID: 18630618
    [Abstract] [Full Text] [Related]

  • 52. Syzygium cumini (L.) SKEELS (Myrtaceae) against diabetes--125 years of research.
    Helmstädter A.
    Pharmazie; 2008 Feb 25; 63(2):91-101. PubMed ID: 18380393
    [Abstract] [Full Text] [Related]

  • 53. The arylsulfonylureas: twelve month clinical study in 814 patients with diabetes mellitus.
    SZUCS MM, EUSEBI AJ, PETRAGLIA S.
    Am Pract Dig Treat; 1958 Sep 25; 9(9):1415-8. PubMed ID: 13571583
    [No Abstract] [Full Text] [Related]

  • 54. Quinine-associated hypoglycaemia causing diabetes.
    Kerr D, Bdiri A.
    Diabet Med; 2008 Feb 25; 25(2):241-2. PubMed ID: 18290865
    [No Abstract] [Full Text] [Related]

  • 55. Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis.
    Czech M, Rdzanek E, Pawęska J, Adamowicz-Sidor O, Niewada M, Jakubczyk M.
    BMC Endocr Disord; 2015 Oct 12; 15():57. PubMed ID: 26458540
    [Abstract] [Full Text] [Related]

  • 56. Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes.
    Freemantle N, Balkau B, Danchin N, Wang E, Marre M, Vespasiani G, Kawamori R, Home PD.
    Diabetes Obes Metab; 2012 Oct 12; 14(10):901-9. PubMed ID: 22519930
    [Abstract] [Full Text] [Related]

  • 57. Study design and baseline characteristics of patients in the PRESENT study.
    Shestakova M, Bech OM, Momani MS.
    Diabetes Res Clin Pract; 2008 Sep 12; 81 Suppl 1():S3-9. PubMed ID: 18672309
    [Abstract] [Full Text] [Related]

  • 58. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 12; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 59. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 12; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 60. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group.
    Diabetes Obes Metab; 2008 Mar 12; 10(3):212-22. PubMed ID: 18269636
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.